Coronary Plaque Imaging for Non-Invasive CAD Risk Stratification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for non-invasive plaque analysis in coronary arteries lack comprehensive and accurate assessment of plaque characteristics, such as distance, volume, and morphology, which are crucial for determining the risk of coronary artery disease (CAD) and generating effective treatment plans.

Innovation Solution

Systems and methods for non-invasive image-based plaque analysis that include identifying low-density non-calcified plaque regions, determining distances to vessel walls, assessing plaque embeddedness and shape, and using machine learning algorithms to generate a risk assessment of CAD, based on medical images from techniques like CT, ultrasound, and MRI.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If invasive procedures like angioplasty and stent are performed, then treatment can be provided, but unnecessary invasive procedures occur due to inaccurate identification of unstable plaque

Engineering Contradiction:
Improveaccuracy of unstable plaque identificationVSAvoidunnecessary invasive procedures
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system performs preliminary non-invasive CT imaging and plaque analysis before invasive procedures are considered. By pre-identifying unstable plaque characteristics (low radiodensity, specific morphology, embeddedness in vessel wall), the system enables clinicians to target invasive procedures only to patients with confirmed high-risk plaque, thereby avoiding unnecessary interventions in stable plaque cases.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces invasive mechanical diagnostic procedures with non-invasive CT imaging and automated image analysis algorithms. The system uses computational methods to assess plaque stability based on radiodensity measurements and morphological features, substituting the need for invasive angiography and physical examination while improving diagnostic accuracy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If blood tests and drug treatments are used, then treatment can be provided, but significant cardiovascular risk areas are missed

Engineering Contradiction:
Improvedetection of cardiovascular riskVSAvoidcardiovascular risk areas
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The system segments the coronary artery into distinct regions and characterizes plaque in each segment individually. By dividing the vasculature and analyzing plaque morphology, density, and location in each segment, the system identifies specific high-risk areas that would be missed by global blood tests, enabling targeted treatment of significant cardiovascular risk areas.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces CT imaging and automated image analysis as an intermediary between blood tests and clinical decision-making. This intermediary provides direct visualization and quantitative assessment of plaque characteristics, bridging the gap between non-specific blood markers and specific anatomical risk areas, thereby preventing loss of critical risk information.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If non-invasive CT imaging and automated analysis are performed, then accurate plaque identification is achieved, but device complexity increases

Engineering Contradiction:
Improveplaque parameter quantificationVSAvoidimaging and analysis system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system employs automated image analysis algorithms that self-process the CT images without requiring manual measurement or interpretation. The software automatically segments plaque, calculates radiodensity, determines morphology, and generates risk assessments, making the complex analysis functions self-executing and reducing the operational burden on clinicians despite the underlying system complexity.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent transforms complex imaging data into simplified quantitative parameters (radiodensity values, plaque volume, morphology indices) that can be directly interpreted for clinical decision-making. By changing the representation of complex plaque characteristics into standardized numerical parameters, the system maintains measurement precision while making the output accessible and actionable for clinicians.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provide a detailed and accurate risk assessment of CAD by analyzing plaque characteristics, enabling personalized treatment recommendations and improved diagnostic capabilities for cardiovascular diseases.

Implementation Method 1

analyzing the identified one or more regions of plaque to identify one or more regions of low density non-calcified plaque, non-calcified plaque, or calcified plaque based at least in part on density

Methodology Applied
Scientific EffectX-ray attenuation: X-Ray

Data Source

PatentUS12620092B2Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination
Publication Date: 2026.05.05 CLEERLY INC
  • US12620092B2 patent drawing
  • US12620092B2 patent drawing
  • US12620092B2 patent drawing

AI summary

Systems and methods of facilitating determination of risk of coronary artery disease (CAD) based at least in part on one or more measurements derived from non-invasive medical image analysis. The methods can include accessing a non-invasive generated medical image, identifying one or more arteries, identifying, regions of plaque within an artery, analyzing the regions of plaque to identify low density non-calcified plaque, non-calcified plaque, or calcified plaque based at least in part on density, determining a distance from identified regions of low density non-calcified plaque to one or more of a lumen wall or vessel wall, determining embeddedness of the regions of low density non-calcified plaque by one or more of non-calcified plaque or calcified plaque, determining a shape of the more regions of low density non-calcified plaque, and generating a display of the analysis to facilitate determination of one or more of a risk of CAD of the subject.